Jaguar Health (JAGX) Asset Utilization Ratio (2015 - 2026)
Jaguar Health's (JAGX) quarterly Asset Utilization Ratio came in at 1.43 in Q1 2026, up 547.94% year-on-year from 0.22 in Q1 2025, and up 231.51% on a QoQ basis from 0.43 in Q4 2025.
Jaguar Health (JAGX) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 12 years of Asset Utilization Ratio data on file, last reported at 1.43 in Q1 2026.
- On a quarterly basis, Asset Utilization Ratio rose 547.94% year-over-year to 1.43 in Q1 2026; TTM through Mar 2026 was 1.43, a 547.94% increase from a year earlier, with the FY2025 full-year figure at 0.4, up 78.67% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 1.43, up from 0.43 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for JAGX reached as high as 1.43 in Q1 2026 and fell as low as 0.06 in Q1 2022.
- Historically, Asset Utilization Ratio has averaged 0.25 across 5 years, with a median of 0.17 in 2024.
- Across the five-year window, Asset Utilization Ratio slipped 29.83% in 2023 and surged 547.94% in 2026, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.12 in 2022, then jumped by 30.94% to 0.16 in 2023, then advanced by 29.02% to 0.21 in 2024, then jumped by 106.07% to 0.43 in 2025, then surged by 231.51% to 1.43 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 1.43 in Q1 2026, 0.43 in Q4 2025, and 0.24 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,782.24 Bn | 1,782.18 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.46 Bn | 468.66 Bn | 1.35 Bn | 0.69 |
| 4 | Vertex Pharmaceuticals | 123.84 Bn | 116.59 Bn | 2.59 Bn | 0.47 |
| 5 | Regeneron Pharmaceuticals | 71.69 Bn | 62.94 Bn | 3.31 Bn | 0.37 |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.74 Bn | 49.55 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.08 Bn | 35.07 Bn | 959.66 Mn | 0.85 |
| 9 | Revolution Medicines | 36.07 Bn | 36.07 Bn | - | - |
| 10 | Jaguar Health | 520,945.88 | -9.54 Mn | 19.11 Mn | 1.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.43 |
| Dec 31, 2025 | 0.43 |
| Sep 30, 2025 | 0.24 |
| Jun 30, 2025 | 0.24 |
| Mar 31, 2025 | 0.22 |
| Dec 31, 2024 | 0.21 |
| Sep 30, 2024 | 0.17 |
| Jun 30, 2024 | 0.17 |
| Mar 31, 2024 | 0.19 |
| Dec 31, 2023 | 0.16 |
| Sep 30, 2023 | 0.11 |
| Jun 30, 2023 | 0.11 |
| Mar 31, 2023 | 0.12 |
| Dec 31, 2022 | 0.12 |
| Sep 30, 2022 | 0.16 |
| Jun 30, 2022 | 0.11 |
| Mar 31, 2022 | 0.06 |
| Dec 31, 2021 | 0.08 |
| Sep 30, 2021 | 0.07 |
| Jun 30, 2021 | 0.06 |